15 drugs reach their earliest generic-entry date in 2045

When

Applicant (as listed)

Basis

Jan 2045 · 1

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Epinephrine NDA 215425 · Solution · intramuscular, intravenous, subcutaneous epinephrine	epinephrine	Fresenius Kabi Usa	17 Jan 2045 patent	patent

Feb 2045 · 2

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Rezdiffra NDA 217785 · Tablet · oral · 3 strengths resmetirom	resmetirom	Madrigal	4 Feb 2045 patent, carve-out possible	patent, carve-out possible
Lamlique NDA 221109 · Suspension · oral · 2 strengths lamotrigine hemifumarate	lamotrigine hemifumarate	Azurity	14 Feb 2045 patent	patent

Mar 2045 · 1

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Symbravo NDA 215431 · Tablet · oral meloxicam; rizatriptan benzoate	meloxicam; rizatriptan benzoate	Axsome	10 Mar 2045 patent, carve-out possible	patent, carve-out possible

Apr 2045 · 3

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Kyxata NDA 219921 · Solution · intravenous · 2 strengths carboplatin	carboplatin	Avyxa Holdings	1 Apr 2045 patent	patent
Hyftor NDA 213478 · Gel · topical sirolimus	sirolimus	Nobelpharma	11 Apr 2045 patent	patent
Romvimza NDA 219304 · Capsule · oral · 3 strengths vimseltinib	vimseltinib	Deciphera Pharms	30 Apr 2045 patent	patent

May 2045 · 2

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Enbumyst NDA 219500 · Spray · nasal bumetanide	bumetanide	Corstasis Therap	14 May 2045 patent	patent
Lynkuet NDA 219469 · Capsule · oral elinzanetant	elinzanetant	Bayer Hlthcare	14 May 2045 patent, carve-out possible	patent, carve-out possible

Jun 2045 · 1

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Axtle NDA 210661 · Powder · intravenous · 2 strengths pemetrexed dipotassium	pemetrexed dipotassium	Avyxa Holdings	25 Jun 2045 patent	patent

Jul 2045 · 1

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Zunveyl NDA 218549 · Tablet, delayed release · oral · 3 strengths benzgalantamine gluconate	benzgalantamine gluconate	Alpha Cognition	23 Jul 2045 patent, carve-out possible	patent, carve-out possible

Aug 2045 · 1

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Qlonilik NDA 221094 · Solution · oral clonidine hydrochloride	clonidine hydrochloride	Cmp Dev Llc	22 Aug 2045 patent	patent

Sep 2045 · 2

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Hemiclor NDA 218647 · Tablet · oral chlorthalidone	chlorthalidone	Prm Pharma	4 Sep 2045 patent	patent
Vyscoxa NDA 211759 · Suspension · oral celecoxib	celecoxib	Carwin Pharm Assoc	17 Sep 2045 patent	patent

Nov 2045 · 1

Drug	Ingredient	Applicant	Earliest generic entry	Basis
Sernivo NDA 208079 · Spray · topical betamethasone dipropionate	betamethasone dipropionate	Primus Pharms	19 Nov 2045 patent, carve-out possible	patent, carve-out possible